Invesco Pharmaceuticals ETF
PJPNYSEARCAInvescoEquity
As of Oct 16, 2026 close
- Assets (AUM)
- $571.00M
- Expense ratio
- 0.58%
- Dividend yield
- 0.90%
- Holdings
- 31
- 52-week range
- $92.73$131.68
- Volume (live)
- -
- Avg. volume (3M)
- 36.34K
PJP ETF: Invesco Pharmaceuticals ETF - Price, Holdings & Analysis
Invesco Pharmaceuticals ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $124.07 - $125.14 |
|---|---|
| 52-Week High | $131.68 |
| 52-Week Low | $92.73 |
| Open | $125.13 |
| Volume (last close) | 27.47K |
| Average Volume (3M) | 36.34K |
| 1 Day Change | +1.40% |
|---|---|
| 1 Month Change | −0.64% |
| 6 Month Change | +16.60% |
| YTD Change | +19.87% |
| 1 Year Change | +33.02% |
| 5 Year Change | +60.90% |
| 10 Year Change | +113.86% |
| Annual Dividend | $1.13 |
|---|---|
| Dividend Yield | 0.90% |
| Last Dividend Ex-Date | Sep 21, 2026 |
| Dividend Growth YoY | +13.08% |
| Years Dividend Growth | 5 |
| Assets (AUM) | $571.00M |
|---|---|
| Expense Ratio | 0.58% |
| Total Holdings | 31 |
| Inception Date | Jun 22, 2005 |
| 50-Day MA | $125.75 |
|---|---|
| 200-Day MA | $113.20 |
| RSI | 48.70 |
| Stochastic %K | 54.16 |
| Stochastic %D | 43.81 |
Source: Exchange price data and fund disclosures. Data as of Oct 16, 2026. Data sources and methodology
PJP at a Glance
Invesco Pharmaceuticals ETF (PJP) is an equity ETF from Invesco, launched in June 2005. It manages $571.00M in assets and charges a 0.58% expense ratio, about $58 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 31 positions. The largest are AbbVie Inc. (ABBV, 5.67%), Pfizer Inc. (PFE, 5.58%) and Gilead Sciences, Inc. (GILD, 5.58%). The top 10 holdings make up 50.3% of the fund. By sector it leans toward Healthcare (100.0%). 100.0% of assets are in the United States.
It pays distributions yielding 0.90% at the Oct 16, 2026 close, $1.13 per share over the trailing 12 months. As of the Oct 16, 2026 close, the share price is up 33.0% over one year, up 60.9% over five years and up 113.9% over ten years (price change, excluding distributions).
Frequently Asked Questions About Invesco Pharmaceuticals ETF
What is the current price of PJP?
The latest PJP price is $124.46 (Oct 16, 2026 close). The 52-week range is $92.73–$131.68. The share price is up 33.0% over the past year (price change, excluding distributions).
What is the expense ratio for PJP?
PJP's annual expense ratio is 0.58%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does PJP pay dividends?
Yes, PJP pays a 0.90% dividend yield (trailing 12 months, at the Oct 16, 2026 close). The most recent ex-dividend date was September 21, 2026. View full dividend history in the Dividends section.
What are the top holdings of PJP?
As of Oct 4, 2026, PJP's largest holdings are AbbVie Inc. (5.7%), Pfizer Inc. (5.6%), Gilead Sciences, Inc. (5.6%) (combined weight: 16.8%). The fund holds 31 total positions. View the complete portfolio breakdown in the Holdings section.
How does PJP compare to similar ETFs?
Compare PJP (0.58% expense ratio, $571M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.